Quote | Chardan Healthcare Acquisition 2 Corp. (NYSE:CHAQ)
Last: | $8.41 |
---|---|
Change Percent: | -10.15% |
Open: | $9.35 |
Close: | $8.41 |
High: | $9.35 |
Low: | $8.06 |
Volume: | 241,663 |
Last Trade Date Time: | 09/02/2021 04:43:44 am |
News | Chardan Healthcare Acquisition 2 Corp. (NYSE:CHAQ)
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc. PR Newswire NEW YORK , Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition com...
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer - Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac diseases PR N...
Message Board Posts | Chardan Healthcare Acquisition 2 Corp. (NYSE:CHAQ)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Chardan Healthcare Acquisition 2 Corp. Company Name:
CHAQ Stock Symbol:
NYSE Market:
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc. PR Newswire NEW YORK , Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition com...
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer - Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac diseases PR N...
Chardan Healthcare Acquisition 2 Corp. Announces Record Date for Stockholders Eligible to Vote on Merger PR Newswire PHILADELPHIA and NEW YORK , Aug. 3, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (the "Company") announced that the close ...